February 2023 Update
In February 2023, the court was considering final pretrial motions for the upcoming June 2023 trial. Additionally, two other significant lawsuits were scheduled to go to trial later in the year, on October 2, 2023, and November 29, 2023. These bellwether trials are seen as important for setting the tone for future cases.In February 2023, the court was considering final pretrial motions for the upcoming June 2023 trial. Additionally, two other significant lawsuits were scheduled to go to trial later in the year, on October 2, 2023, and November 29, 2023. These bellwether trials are seen as important for setting the tone for future cases.
September 2022 Update
A major development occurred when U.S. District Judge Wendy Beetlestone set the date for the first trial in the Injectafer litigation, scheduled to begin on June 5, 2023. While the outcome of this trial won’t directly affect other lawsuits, it is expected to influence the direction of future settlement talks and negotiations to avoid the need for more trials.
August 2021 Update
As lawsuits against Injectafer continued to move forward in the Eastern District of Pennsylvania, many plaintiffs claimed that the drug manufacturer failed to warn about the risks associated with the drug, particularly dangerous side effects like hypophosphatemia. In response, a motion was filed to combine two of the cases for a single trial to save judicial resources. However, the court decided to hold separate trials for the first two bellwether cases, meaning they would be tried individually to better understand how juries may respond to the evidence presented.
August 2019 Update
A study published in August 2019 lent support to the growing number of lawsuits against Injectafer, confirming that the drug can cause hypophosphatemia (HPP), a condition in which phosphorus levels in the body become dangerously low. This condition is linked to severe health complications, including muscle weakness and bone pain, which were central to many of the claims brought against the manufacturer.